Whey protein and building muscle: the sum greater than the parts?
A supplement containing whey protein can boost the building of muscle in the elderly, with the effects beyond that of just the amino acid content, says a new study.
Archives for October 29, 2008
Kellogg’s ups ante on cholesterol campaign
Kellogg ’s in the UK has joined with one of the country’s leading heart health charities to launch a series of initiatives aimed at lowering cholesterol and reducing the incidence of cardio vascular disease (CVD).
Section 912 and the blurring of the supplement-drug line
The US Food and Drug Administration (FDA) yesterday said it is extending the comment period for Section 912 of its Amendments Act (FDAAA), which has the potential to radically change the way dietary supplements are regulated in the country.
EFSA opinion prompts Finland to reassess Valio health claim
The Finnish Food Safety Authority (Evira) will investigate an “arterial elasticity” health claim being made by Finnish dairy, Valio, about a peptide- and plant sterol-bearing dairy/juice drink after the European Food Safety Authority (EFSA) turned down a...
What is Section 912?
Stuart Craig, Danisco's director of Regulatory and Scientific Affairs, North America, explains why Section 912 could have a major impact on the way dietary supplements are regulated in the United States.
Exploring the sweet future for stevia
As regulatory approval for stevia and its extracts gathers pace in the US, Mark Blumenthal from the American Botanical Council gives his thoughts and inside knowledge on his nominee for ‘herb of the year’.
Grapes may protect against salt-induced hypertension: study
A diet rich in phytochemicals from grapes may reduce the blood pressure increases associated with high salt intake, according to a new animal study.
Could heart-healthy pistachios be the new pomegranate?
Pistachio growers in the US are hoping that as another study emerges highlighting the health benefits of pistachios, the nuts may gain the kind of consumer recognition pomegranates have achieved in recent years.
FDA raps Bayer in ‘combo' product crackdown
In a move that has divided industry, the Food and Drug Administration (FDA) has told German pharma giant Bayer in no uncertain terms to cease making disease reduction claims about products that contain both pharmaceutical and nutraceutical ingredients.